These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 21308736

  • 1. Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion.
    Zhang JY, Mi YJ, Chen SP, Wang F, Liang YJ, Zheng LS, Shi CJ, Tao LY, Chen LM, Chen HB, Fu LW.
    J Cell Biochem; 2011 Apr; 112(4):1076-83. PubMed ID: 21308736
    [Abstract] [Full Text] [Related]

  • 2. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.
    Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 28; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 9. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 28; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D, Lu Q, Hu X.
    Cancer Lett; 2006 Nov 18; 243(2):274-80. PubMed ID: 16406853
    [Abstract] [Full Text] [Related]

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A, Wang X, Xiang W, Liang H, Gao J, Yan Y.
    J Pharm Pharmacol; 2010 Mar 18; 62(3):393-9. PubMed ID: 20487225
    [Abstract] [Full Text] [Related]

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 18; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
    Zhang J, Lu M, Zhou F, Sun H, Hao G, Wu X, Wang G.
    Drug Metab Dispos; 2012 Oct 18; 40(10):1900-8. PubMed ID: 22745335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R, Li W, Zhang X, Zhang Y, Peng H, Xie Y, Fan D, Liu R, Liu X, Xiong D.
    Eur J Pharmacol; 2011 Nov 01; 669(1-3):38-44. PubMed ID: 21871878
    [Abstract] [Full Text] [Related]

  • 17. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.
    J Pharm Pharmacol; 2007 Dec 01; 59(12):1649-55. PubMed ID: 18053326
    [Abstract] [Full Text] [Related]

  • 18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 19. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells.
    Duarte N, Gyémánt N, Abreu PM, Molnár J, Ferreira MJ.
    Planta Med; 2006 Feb 01; 72(2):162-8. PubMed ID: 16491453
    [Abstract] [Full Text] [Related]

  • 20. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A, Liang H, Wang X, Zhang X, Jing M, Zhang J, Yan Y, Xiang W.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):108-13. PubMed ID: 21458446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.